Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Clinical trial NCT02408861 · TERMINATED

Trial details

NCT number: NCT02408861
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Solid Neoplasm Anal Carcinoma HIV Infection Kaposi Sarcoma Lung Carcinoma Metastatic Malignant Solid Neoplasm Recurrent Classic Hodgkin Lymphoma Refractory Classic Hodgkin Lymphoma Unresectable Solid Neoplasm HIV-associated Cancers

Start date: 2015-10-21
Primary completion: 2024-05-01
Enrollment: 79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.